Alps Group Inc.

ALPS Healthcare Biotechnology

Alps Group Inc.’s revenue for fiscal 2026 (year ended March 2026) was $4.9 million, up 44.1% from fiscal 2025. In the quarter to September 2025, EPS fell 609.4% and free cash flow fell 26.5%, each against the same quarter a year earlier.

0.34 0.00 0.00%
Market cap
$56.4M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
−1.64
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jan '21 Dec '21 Jan '22 Dec '22 Dec '23 Dec '24 Mar '25 Mar '26
Total current assets
1.03 1.03 — 0.29 0.20 0.35 1.49 1.97
Total non-current assets
— 116.93 — 118.41 28.67 3.35 5.64 4.99
Total Assets
117.96 117.96 — 118.70 28.87 3.70 7.13 6.97
Total current liabilities
0.23 0.23 — 0.78 4.17 7.14 7.49 5.48
Total non-current liabilities
— 120.86 — 121.98 31.97 7.25 0.76 4.72
Total liabilities
4.37 121.10 — 122.75 36.14 14.39 8.25 10.20
Common Equity (Total)
113.59 (3.14) — (4.05) (7.26) (10.69) (1.12) (3.23)
Shareholders Equity (Total)
113.59 (3.14) — (4.05) (7.26) (10.69) (1.12) (3.23)

Show all line items

In millions of $ except per-share values · columns are period end dates